Biofil Chemicals & Pharmaceuticals Limited Financial Ratios
BIOFILCHEM · Healthcare · Current price ₹30.48
P/E ratio
17.8x
P/B ratio
2.8x
ROE
12.9%
ROCE
14.1%
Debt / Equity
0.14
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 17.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 12.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 14.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.14 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Biofil Chemicals & Pharmaceuticals Limited's latest numbers.
Biofil Chemicals & Pharmaceuticals Limited profitability
Biofil Chemicals & Pharmaceuticals Limited generates a return on equity of 12.9% and a return on capital employed of 14.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.14 and a P/E of 17.8x, Biofil Chemicals & Pharmaceuticals Limited is conservatively financed. Our overall business-quality score for the company is 5.1 / 10.
Understand the ratios
More on Biofil Chemicals & Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.